A Phase I, Randomised, Open-label, Cross-over, Single-centre Study in Healthy Male and Non-fertile Female Volunteers to Determine the Relative Bioavailability of the Phase II Wet Granulation Tablet Formulation Compared to the Phase II/III Roller Compacted Tablet Formulation of AZD8931

Trial Profile

A Phase I, Randomised, Open-label, Cross-over, Single-centre Study in Healthy Male and Non-fertile Female Volunteers to Determine the Relative Bioavailability of the Phase II Wet Granulation Tablet Formulation Compared to the Phase II/III Roller Compacted Tablet Formulation of AZD8931

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jul 2011

At a glance

  • Drugs Sapitinib (Primary)
  • Indications Breast cancer; Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Jul 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
    • 27 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top